Richard J. Rodeheffer

32.2k total citations · 11 hit papers
198 papers, 23.8k citations indexed

About

Richard J. Rodeheffer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard J. Rodeheffer has authored 198 papers receiving a total of 23.8k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Cardiology and Cardiovascular Medicine, 53 papers in Surgery and 23 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard J. Rodeheffer's work include Cardiovascular Function and Risk Factors (83 papers), Heart Failure Treatment and Management (69 papers) and Transplantation: Methods and Outcomes (31 papers). Richard J. Rodeheffer is often cited by papers focused on Cardiovascular Function and Risk Factors (83 papers), Heart Failure Treatment and Management (69 papers) and Transplantation: Methods and Outcomes (31 papers). Richard J. Rodeheffer collaborates with scholars based in United States, Italy and Netherlands. Richard J. Rodeheffer's co-authors include Margaret M. Redfield, Steven J. Jacobsen, Douglas W. Mahoney, John C. Burnett, Kent R. Bailey, Barry A. Borlaug, Véronique L. Roger, Carolyn S.P. Lam, Lynn H. Urban and Denise M. Heublein and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Richard J. Rodeheffer

192 papers receiving 23.0k citations

Hit Papers

Burden of Systolic and Diastolic Ventricular Dy... 1984 2026 1998 2012 2003 1991 1995 2004 2009 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
    2003 2.3k citations Margaret M. Redfield, Steven J. Jacobsen et al. profile →
  2. Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
    1991 1.6k citations Milton Packer, Joseph R. Carver et al. New England Journal of Medicine profile →
  3. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy.
    1995 1.3k citations Richard J. Rodeheffer et al. profile →
  4. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure
    2004 1.0k citations Yuji Okura, Lynn H. Urban et al. Journal of Clinical Epidemiology profile →
  5. Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
    2009 987 citations Carolyn S.P. Lam, Véronique L. Roger et al. Journal of the American College of Cardiology profile →
  6. Plasma brain natriuretic peptide concentration: impact of age and gender
    2002 864 citations Margaret M. Redfield, Richard J. Rodeheffer et al. Journal of the American College of Cardiology profile →
  7. Congestive Heart Failure in the Community
    1998 847 citations Richard J. Rodeheffer, Steven J. Jacobsen et al. Circulation profile →
  8. Age- and Gender-Related Ventricular-Vascular Stiffening
    2005 620 citations Margaret M. Redfield, Steven J. Jacobsen et al. Circulation profile →
  9. The Frequency of Familial Dilated Cardiomyopathy in a Series of Patients with Idiopathic Dilated Cardiomyopathy
    1992 495 citations John C. Burnett, Richard J. Rodeheffer et al. New England Journal of Medicine profile →
  10. Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure
    2011 490 citations Garvan C. Kane, Douglas W. Mahoney et al. profile →
  11. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate.
    1984 476 citations Richard J. Rodeheffer et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard J. Rodeheffer United States 68 18.1k 3.7k 3.2k 3.0k 2.2k 198 23.8k
Frank Ruschitzka Switzerland 61 14.8k 0.8× 3.8k 1.0× 2.2k 0.7× 2.7k 0.9× 1.9k 0.8× 384 21.4k
Marvin A. Konstam United States 72 21.7k 1.2× 4.5k 1.2× 2.0k 0.6× 5.6k 1.9× 2.5k 1.1× 321 29.1k
Mark H. Drazner United States 57 14.4k 0.8× 3.3k 0.9× 1.8k 0.6× 2.3k 0.8× 1.7k 0.8× 236 18.9k
Torbjørn Omland Norway 57 13.6k 0.8× 3.0k 0.8× 2.5k 0.8× 3.1k 1.0× 1.8k 0.8× 332 18.6k
Ileana L. Piña United States 79 19.6k 1.1× 2.9k 0.8× 1.6k 0.5× 3.0k 1.0× 1.1k 0.5× 351 27.0k
Philip A. Poole‐Wilson United Kingdom 70 18.0k 1.0× 3.1k 0.8× 2.0k 0.6× 3.1k 1.1× 3.3k 1.5× 202 26.4k
G. Michael Felker United States 83 17.3k 1.0× 4.3k 1.2× 1.3k 0.4× 4.2k 1.4× 2.5k 1.1× 417 24.0k
Stefan Blankenberg Germany 77 10.7k 0.6× 5.1k 1.4× 2.6k 0.8× 2.3k 0.8× 3.7k 1.7× 671 22.0k
Biykem Bozkurt United States 66 19.4k 1.1× 6.9k 1.9× 1.9k 0.6× 5.2k 1.7× 2.3k 1.1× 251 27.7k
Inder S. Anand United States 81 17.6k 1.0× 2.9k 0.8× 1.6k 0.5× 3.0k 1.0× 1.6k 0.7× 420 23.2k

Countries citing papers authored by Richard J. Rodeheffer

Since Specialization
Citations

This map shows the geographic impact of Richard J. Rodeheffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Rodeheffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Rodeheffer more than expected).

Fields of papers citing papers by Richard J. Rodeheffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Rodeheffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Rodeheffer. The network helps show where Richard J. Rodeheffer may publish in the future.

Co-authorship network of co-authors of Richard J. Rodeheffer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Rodeheffer. A scholar is included among the top collaborators of Richard J. Rodeheffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Rodeheffer. Richard J. Rodeheffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Churchill, Robert, Christopher G. Scott, Vlad C. Vasile, et al.. (2024). Association of cardiac biomarkers with long-term cardiovascular events in a community cohort. Biomarkers. 29(4). 161–170. 3 indexed citations
2.
Young, Kathleen A., Christopher G. Scott, Richard J. Rodeheffer, & Horng H. Chen. (2022). Incidence of Preclinical Heart Failure in a Community Population. Journal of the American Heart Association. 11(15). e025519–e025519. 7 indexed citations
3.
Young, Kathleen A., Christopher G. Scott, Richard J. Rodeheffer, & Horng H. Chen. (2021). Progression of Preclinical Heart Failure: A Description of Stage A and B Heart Failure in a Community Population. Circulation Cardiovascular Quality and Outcomes. 14(5). e007216–e007216. 15 indexed citations
4.
Scott, Christopher G., et al.. (2020). Diabetes Mellitus Is an Independent Predictor for the Development of Heart Failure. Mayo Clinic Proceedings. 95(1). 124–133. 23 indexed citations
5.
Eiger, Daniel, Noam Pondé, Dominique Agbor‐Tarh, et al.. (2020). Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial. British Journal of Cancer. 122(10). 1453–1460. 23 indexed citations
6.
Davis, John M., Grace Lin, Jae K. Oh, et al.. (2017). Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population. International Journal of Cardiology. 240. 379–385. 41 indexed citations
7.
Moreno‐Aspitia, Alvaro, Amylou C. Dueck, Tejal Patel, et al.. (2013). RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer. Breast Cancer Research and Treatment. 138(2). 427–435. 14 indexed citations
8.
Mohammed, Selma F., Barry A. Borlaug, Véronique L. Roger, et al.. (2012). Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction. Circulation Heart Failure. 5(6). 710–719. 154 indexed citations
9.
Lam, Carolyn S.P., Barry A. Borlaug, Garvan C. Kane, et al.. (2009). Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population. Circulation. 119(20). 2663–2670. 314 indexed citations
10.
Borlaug, Barry A., Carolyn S.P. Lam, Véronique L. Roger, Richard J. Rodeheffer, & Margaret M. Redfield. (2009). Contractility and Ventricular Systolic Stiffening in Hypertensive Heart Disease. Journal of the American College of Cardiology. 54(5). 410–418. 316 indexed citations
11.
Lam, Carolyn S.P., Barry A. Borlaug, Garvan C. Kane, Richard J. Rodeheffer, & Margaret M. Redfield. (2008). Abstract 6206: Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population. Circulation. 118. 1128–1134. 1 indexed citations
12.
Perez, Edith A., Vera J. Suman, Nancy E. Davidson, et al.. (2008). Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial. Journal of Clinical Oncology. 26(8). 1231–1238. 402 indexed citations
13.
Ammar, Khawaja Afzal, Steven J. Jacobsen, Douglas W. Mahoney, et al.. (2007). Prevalence and Prognostic Significance of Heart Failure Stages. Circulation. 115(12). 1563–1570. 351 indexed citations
14.
Costello‐Boerrigter, Lisa C., Guido Boerrigter, Margaret M. Redfield, et al.. (2006). Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community. Journal of the American College of Cardiology. 47(2). 345–353. 305 indexed citations
15.
Redfield, Margaret M., Steven J. Jacobsen, Barry A. Borlaug, Richard J. Rodeheffer, & David A. Kass. (2005). Age- and Gender-Related Ventricular-Vascular Stiffening. Circulation. 112(15). 2254–2262. 620 indexed citations breakdown →
16.
Okura, Yuji, Lynn H. Urban, Douglas W. Mahoney, Steven J. Jacobsen, & Richard J. Rodeheffer. (2004). Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. Journal of Clinical Epidemiology. 57(10). 1096–1103. 1004 indexed citations breakdown →
17.
Rodeheffer, Richard J.. (2004). Measuring plasma B-type natriuretic peptide in heart failureGood to go in 2004?. Journal of the American College of Cardiology. 44(4). 740–749. 38 indexed citations
18.
Berger, Peter B., James D. Jones, Lyle J. Olson, et al.. (1995). Increase in Total Plasma Homocysteine Concentration After Cardiac Transplantation. Mayo Clinic Proceedings. 70(2). 125–131. 49 indexed citations
19.
Packer, Milton, Joseph R. Carver, Richard J. Rodeheffer, et al.. (1991). Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure. New England Journal of Medicine. 325(21). 1468–1475. 1602 indexed citations breakdown →
20.
Rodeheffer, Richard J., Issei Tanaka, Teruaki Imada, et al.. (1986). Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. Journal of the American College of Cardiology. 8(1). 18–26. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Ruschitzka Breakdown of academic impact, for papers by Marvin A. Konstam Breakdown of academic impact, for papers by Mark H. Drazner Breakdown of academic impact, for papers by Torbjørn Omland Breakdown of academic impact, for papers by Ileana L. Piña Breakdown of academic impact, for papers by Philip A. Poole‐Wilson Breakdown of academic impact, for papers by G. Michael Felker Breakdown of academic impact, for papers by Stefan Blankenberg Breakdown of academic impact, for papers by Biykem Bozkurt Breakdown of academic impact, for papers by Inder S. Anand
Rankless by CCL
2026